Ethical Considerations and Compliance with Good Clinical Practice (Part 12 of Safety and Efficacy of Imatinib for Preserving Beta-Cell Function in New-onset Type 1 Diabetes Mellitus) v1 (protocols.io.bvein3ce)

protocols.io ◽

10.17504/protocols.io.bvein3ce ◽

2021 ◽

Author(s):

Stephen.Gitelman not provided ◽

Jeffrey A.

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Clinical Practice ◽

Beta Cell Function ◽

Cell Function ◽

Good Clinical Practice ◽

Ethical Considerations ◽

Safety And Efficacy ◽

New Onset

Download Full-text

Access to Source Data/Documents (Part 10 of Safety and Efficacy of Imatinib for Preserving Beta-Cell Function in New-onset Type 1 Diabetes Mellitus) v1 (protocols.io.bvegn3bw)

protocols.io ◽

10.17504/protocols.io.bvegn3bw ◽

2021 ◽

Author(s):

Stephen.Gitelman not provided ◽

Jeffrey A.

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Beta Cell ◽

Type 1 Diabetes Mellitus ◽

Beta Cell Function ◽

Cell Function ◽

Safety And Efficacy ◽

Source Data ◽

New Onset

Download Full-text

Schedule of Events (Appendix 1 of "Safety and Efficacy of Imatinib for Preserving Beta-Cell Function in New-onset Type 1 Diabetes Mellitus") v1 (protocols.io.bvf6n3re)

protocols.io ◽

10.17504/protocols.io.bvf6n3re ◽

2021 ◽

Author(s):

Stephen.Gitelman not provided ◽

Jeffrey A.

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Beta Cell ◽

Type 1 Diabetes Mellitus ◽

Beta Cell Function ◽

Cell Function ◽

Safety And Efficacy ◽

Onset Type ◽

New Onset

Download Full-text

Mechanistic Assays (Part 7 of Safety and Efficacy of Imatinib for Preserving Beta-Cell Function in New-onset Type 1 Diabetes Mellitus) v1 (protocols.io.bvdcn22w)

protocols.io ◽

10.17504/protocols.io.bvdcn22w ◽

2021 ◽

Author(s):

Stephen.Gitelman not provided ◽

Jeffrey A.

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Beta Cell ◽

Type 1 Diabetes Mellitus ◽

Beta Cell Function ◽

Cell Function ◽

Safety And Efficacy ◽

Onset Type ◽

New Onset

Download Full-text

Eligibility (Part 4 of Safety and Efficacy of Imatinib for Preserving Beta-Cell Function in New-onset Type 1 Diabetes Mellitus) v1 (protocols.io.bvc4n2yw)

protocols.io ◽

10.17504/protocols.io.bvc4n2yw ◽

2021 ◽

Author(s):

Stephen.Gitelman not provided ◽

Jeffrey A.

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Beta Cell ◽

Type 1 Diabetes Mellitus ◽

Beta Cell Function ◽

Cell Function ◽

Safety And Efficacy ◽

Onset Type ◽

New Onset

Download Full-text

Objectives (Part 2 of Safety and Efficacy of Imatinib for Preserving Beta-Cell Function in New-onset Type 1 Diabetes Mellitus) v1 (protocols.io.bvcvn2w6)

protocols.io ◽

10.17504/protocols.io.bvcvn2w6 ◽

2021 ◽

Author(s):

Stephen.Gitelman not provided ◽

Jeffrey A.

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Beta Cell ◽

Type 1 Diabetes Mellitus ◽

Beta Cell Function ◽

Cell Function ◽

Safety And Efficacy ◽

Onset Type ◽

New Onset

Download Full-text

Adverse Events (Part 8 of Safety and Efficacy of Imatinib for Preserving Beta-Cell Function in New-onset Type 1 Diabetes Mellitus) v1 (protocols.io.bveen3be)

protocols.io ◽

10.17504/protocols.io.bveen3be ◽

2021 ◽

Author(s):

Stephen.Gitelman not provided ◽

Jeffrey A.

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Adverse Events ◽

Beta Cell ◽

Type 1 Diabetes Mellitus ◽

Beta Cell Function ◽

Cell Function ◽

Safety And Efficacy ◽

New Onset

Download Full-text

Collection of Protocols and Guidelines for Safety and Efficacy of Imatinib for Preserving Beta-cell Function in New-onset Type 1 Diabetes Mellitus v1 (protocols.io.bvfqn3mw)

protocols.io ◽

10.17504/protocols.io.bvfqn3mw ◽

2021 ◽

Author(s):

Stephen.Gitelman not provided ◽

Jeffrey A.

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Beta Cell ◽

Type 1 Diabetes Mellitus ◽

Beta Cell Function ◽

Cell Function ◽

Safety And Efficacy ◽

Onset Type ◽

New Onset

Download Full-text

Background and Rationale (Part 1 of Safety and Efficacy of Imatinib for Preserving Beta-Cell Function in New-onset Type 1 Diabetes Mellitus) v1 (protocols.io.bu8knzuw)

protocols.io ◽

10.17504/protocols.io.bu8knzuw ◽

2021 ◽

Author(s):

Stephen.Gitelman not provided ◽

Jeffrey A.

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Beta Cell ◽

Type 1 Diabetes Mellitus ◽

Beta Cell Function ◽

Cell Function ◽

Safety And Efficacy ◽

Onset Type ◽

New Onset

Download Full-text

Study Procedures (Part 6 of Safety and Efficacy of Imatinib for Preserving Beta-Cell Function in New-onset Type 1 Diabetes Mellitus) v1 (protocols.io.bvc9n2z6)

protocols.io ◽

10.17504/protocols.io.bvc9n2z6 ◽

2021 ◽

Author(s):

Stephen.Gitelman not provided ◽

Jeffrey A.

Keyword(s):

Diabetes Mellitus ◽

Type 1 Diabetes ◽

Beta Cell ◽

Type 1 Diabetes Mellitus ◽

Beta Cell Function ◽

Cell Function ◽

Safety And Efficacy ◽

Onset Type ◽

New Onset

Download Full-text

Quality Control and Quality Assurance (Part 11 of Safety and Efficacy of Imatinib for Preserving Beta-Cell Function in New-onset Type 1 Diabetes Mellitus) v1 (protocols.io.bvehn3b6)

protocols.io ◽

10.17504/protocols.io.bvehn3b6 ◽

2021 ◽

Author(s):

Stephen.Gitelman not provided ◽

Jeffrey A.

Keyword(s):

Diabetes Mellitus ◽

Quality Control ◽

Type 1 Diabetes ◽

Quality Assurance ◽

Beta Cell ◽

Beta Cell Function ◽

Cell Function ◽

Safety And Efficacy ◽

New Onset

Download Full-text